UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of Post-second-line Chemotherapy PET Imaging and Involved Field Radiotherapy Prior to High Dose Therapy on Outcomes of Relapsed or Refractory Diffuse Large B Cell Lymphoma

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S125-S126

2008

Volltextzugriff (PDF)

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population

Annals of oncology, 2006-06, Vol.17 (6), p.909-913

2006

Volltextzugriff (PDF)

The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2009-06, Vol.43 (12), p.941-948

2009

Volltextzugriff (PDF)

INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORMED MARGINAL ZONE LYMPHOMA TREATED WITH RCHOP‐LIKE REGIMENS

Hematological oncology, 2019-06, Vol.37 (S2), p.264-266

2019

Volltextzugriff (PDF)

RAPID AND DURABLE RESPONSES WITH THE SYK/JAK INHIBITOR CERDULATINIB IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA—ALONE OR IN COMBINATION WITH RITUXIMAB

Hematological oncology, 2019-06, Vol.37 (S2), p.61-62

2019

Volltextzugriff (PDF)

PF480 THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID AND DURABLE TUMOR RESPONSES IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA ‐ AS A SINGLE AGENT AND COMBINED WITH RITUXIMAB

HemaSphere, 2019-06, Vol.3, p.191-192

2019

Volltextzugriff (PDF)

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma

Annals of oncology, 2007-11, Vol.18 (11), p.1842-1850

2007

Volltextzugriff (PDF)

A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA

Hematological oncology, 2017-06, Vol.35, p.171-172

2017

Volltextzugriff (PDF)

A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 G Y INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK H ODGKIN LYMPHOMA

Hematological oncology, 2017-06, Vol.35 (S2), p.171-172

2017

Volltextzugriff (PDF)

BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET‐ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE

Hematological oncology, 2017-06, Vol.35 (S2), p.36-37

2017

Volltextzugriff (PDF)

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

Hematological oncology, 2017-06, Vol.35 (S2), p.74-74

2017

Volltextzugriff (PDF)

Pralatrexate (PDX) Produces Durable Complete Remissions in Patients with Chemotherapy Resistant Precursor and Peripheral T-Cell Lymphomas: Results of the MSKCC Phase I/II Experience

Blood, 2006-11, Vol.108 (11), p.400-400

2006

Volltextzugriff (PDF)

Pralatrexate (10-Propargyl-10-Deazaaminopterin (PRX)), a Novel Antifolate, Effects Durable Complete Remissions (CR) in Patients with a Diversity of Drug Resistant T-Cell Lymphomas with Minimal Toxicity

Blood, 2005-11, Vol.106 (11), p.2678-2678

2005

Volltextzugriff (PDF)

Promiscuous initiation on mammalian chromosomal DNA templates and its possible suppression by transcription

Experimental cell research, 2005-08, Vol.308 (1), p.53-64

2005

Volltextzugriff (PDF)

Influence of Pressure on the Magnetic Response of the Low-Dimensional Quantum Magnet Cu(H 2 O) 2 (C 2 H 8 N 2 )SO 4

Acta physica Polonica, A, 2017-04, Vol.131 (4), p.901-903

2017

Volltextzugriff (PDF)

Distal Sequences, but Not ori-β/OBR-1, Are Essential for Initiation of DNA Replication in the Chinese Hamster DHFR Origin

Molecular cell, 1998-12, Vol.2 (6), p.797-806

1998

Volltextzugriff (PDF)

Replication forks are associated with the nuclear matrix

Nucleic acids research, 1990-04, Vol.18 (8), p.1965-1969

1990

Volltextzugriff (PDF)

Yeast and mammalian replication intermediates migrate similarly in two-dimensional gels

Chromosoma, 1995, Vol.104 (2), p.92-102

1995

Volltextzugriff (PDF)

Assignment 1 of GALGT encoding β-1,4N-acetylgalactosaminyl-transferase (GalNAc-T) and KIF5A encoding neuronal kinesin (D12S1889) to human chromosome band 12q13 by assignment to ICI YAC 26EG10 and in situ hybridization

Cytogenetic and genome research, 1998-12, Vol.82 (3-4), p.267-268

1998

Volltextzugriff (PDF)

Initiation of replication at a mammalian chromosomal origin

Cold Spring Harbor Symposia on Quantitative Biology, 1993, Vol.58, p.467-474

1993

Volltextzugriff (PDF)

Origins of Replication and the Nuclear Matrix: The DHFR Domain as a Paradigm

International Review of Cytology, 1996, Vol.162, p.455-484

1996

Volltextzugriff (PDF)

Amplification of DNA Sequences in Mammalian Cells

Progress in Nucleic Acid Research and Molecular Biology, 1991, Vol.41, p.203-239

1991

Volltextzugriff (PDF)

Porcine sensitized lymph node cells (immunotherapy) and attenuated irradiation for infiltrative transitional cell carcinoma of bladder

Urology (Ridgewood, N.J.), 1982-01, Vol.19 (6), p.593-597

1982

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)
Buchkapitel
(1)

Sprache

Englisch
(23)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Post-second-line Chemotherapy PET Imaging and Involved Field Radiotherapy Prior to High Dose Therapy on Outcomes of Relapsed or Refractory Diffuse Large B Cell Lymphoma

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population

The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma

INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORMED MARGINAL ZONE LYMPHOMA TREATED WITH RCHOP‐LIKE REGIMENS

RAPID AND DURABLE RESPONSES WITH THE SYK/JAK INHIBITOR CERDULATINIB IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA—ALONE OR IN COMBINATION WITH RITUXIMAB

PF480 THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID AND DURABLE TUMOR RESPONSES IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA ‐ AS A SINGLE AGENT AND COMBINED WITH RITUXIMAB

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma

A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA

A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 G Y INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK H ODGKIN LYMPHOMA

BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET‐ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

Pralatrexate (PDX) Produces Durable Complete Remissions in Patients with Chemotherapy Resistant Precursor and Peripheral T-Cell Lymphomas: Results of the MSKCC Phase I/II Experience

Pralatrexate (10-Propargyl-10-Deazaaminopterin (PRX)), a Novel Antifolate, Effects Durable Complete Remissions (CR) in Patients with a Diversity of Drug Resistant T-Cell Lymphomas with Minimal Toxicity

Promiscuous initiation on mammalian chromosomal DNA templates and its possible suppression by transcription

Influence of Pressure on the Magnetic Response of the Low-Dimensional Quantum Magnet Cu(H 2 O) 2 (C 2 H 8 N 2 )SO 4

Distal Sequences, but Not ori-β/OBR-1, Are Essential for Initiation of DNA Replication in the Chinese Hamster DHFR Origin

Replication forks are associated with the nuclear matrix

Yeast and mammalian replication intermediates migrate similarly in two-dimensional gels

Assignment 1 of GALGT encoding β-1,4N-acetylgalactosaminyl-transferase (GalNAc-T) and KIF5A encoding neuronal kinesin (D12S1889) to human chromosome band 12q13 by assignment to ICI YAC 26EG10 and in situ hybridization

Initiation of replication at a mammalian chromosomal origin

Origins of Replication and the Nuclear Matrix: The DHFR Domain as a Paradigm

Amplification of DNA Sequences in Mammalian Cells

Porcine sensitized lymph node cells (immunotherapy) and attenuated irradiation for infiltrative transitional cell carcinoma of bladder

Suchergebnisse filtern